Literature DB >> 28201839

MR Imaging in Patients with Cardiac Pacemakers and Implantable Cardioverter Defibrillators.

Torsten Sommer1, Wolfgang Bauer2, Katharina Fischbach3, Christof Kolb4, Roger Luechinger5, Uwe Wiegand6, Joachim Lotz7, Ingo Eitel8, Matthias Gutberlet9, Holger Thiele8, Hans H Schild10, Malte Kelm11, Harald H Quick12, Jeanette Schulz-Menger13, Jörg Barkhausen14, Dietmar Bänsch15.   

Abstract

This joint consensus paper of the German Roentgen Society and the German Cardiac Society provides physical and electrophysiological background information and specific recommendations for the procedural management of patients with cardiac pacemakers (PM) and implantable cardioverter defibrillators (ICD) undergoing magnetic resonance (MR) imaging. The paper outlines the responsibilities of radiologists and cardiologists regarding patient education, indications, and monitoring with modification of MR sequences and PM/ICD reprogramming strategies being discussed in particular. The aim is to optimize patient safety and to improve legal clarity in order to facilitate the access of SM/ICD patients to MR imaging. Key Points:  · Conventional PM and ICD systems are no longer an absolute but rather a relative contraindication for performing an MR examination. Procedural management includes the assessment of the individual risk/benefit ratio, comprehensive patient informed consent about specific risks and "off label" use, extensive PM/ICD-related and MR-related safety precautions to reduce these risks to the greatest extent possible, as well as adequate monitoring techniques.. · MR conditional pacemaker and ICD systems have been tested and approved for MR examination under specific conditions ("in-label" use). Precise understanding of and compliance with the terms of use for the specific pacemaker system are essential for patient safety.. · The risk for an ICD patient during MR examinations is to be considered significantly higher compared to PM patients due to the higher vulnerability of the structurally damaged myocardium and the higher risk of irreversible damage to conventional ICD systems. The indication for a MR examination of an ICD patient should therefore be determined on a stricter basis and the expected risk/benefit ratio should be critically reviewed.. · This complex subject requires close collaboration between radiology and cardiology.. Citation Format · Sommer T, Bauer W, Fischbach K et al. MR Imaging in Patients with Cardiac Pacemakers and Implantable Cardioverter Defibrillators. Fortschr Röntgenstr 2017; 189: 204 - 217. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2017        PMID: 28201839     DOI: 10.1055/s-0043-102029

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  10 in total

1.  An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator.

Authors:  Pierpaolo Lupo; Riccardo Cappato; Giovanni Di Leo; Francesco Secchi; Giacomo D E Papini; Sara Foresti; Hussam Ali; Guido M G De Ambroggi; Antonio Sorgente; Gianluca Epicoco; Paola M Cannaò; Francesco Sardanelli
Journal:  Eur Radiol       Date:  2018-01-09       Impact factor: 5.315

2.  Cardiac implanted electronic devices and MRI safety in 2018-the state of play.

Authors:  Ryan Mark Shulman; Ben Hunt
Journal:  Eur Radiol       Date:  2018-04-30       Impact factor: 5.315

3.  Magnetic resonance imaging of patients with epicardial leads: in vitro evaluation of temperature changes at the lead tip.

Authors:  Christian Balmer; Matthias Gass; Hitendu Dave; Firat Duru; Roger Luechinger
Journal:  J Interv Card Electrophysiol       Date:  2019-11-12       Impact factor: 1.900

4.  Detection of cardiac amyloidosis with 18F-Florbetaben-PET/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy.

Authors:  Malte Kircher; Sandra Ihne; Joachim Brumberg; Caroline Morbach; Stefan Knop; K Martin Kortüm; Stefan Störk; Andreas K Buck; Theresa Reiter; Wolfgang R Bauer; Constantin Lapa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-02-23       Impact factor: 9.236

Review 5.  [Safe MRI examinations in patients with pacemakers and ICD].

Authors:  D Beitzke
Journal:  Radiologe       Date:  2019-10       Impact factor: 0.635

6.  Safety and Clinical Impact of MRI in Patients with Non-MRI-conditional Cardiac Devices.

Authors:  Sanjaya K Gupta; Lina Ya'qoub; Alan P Wimmer; Stanley Fisher; Ibrahim M Saeed
Journal:  Radiol Cardiothorac Imaging       Date:  2020-10-22

7.  Portable, low-field magnetic resonance imaging enables highly accessible and dynamic bedside evaluation of ischemic stroke.

Authors:  Matthew M Yuen; Anjali M Prabhat; Mercy H Mazurek; Isha R Chavva; Anna Crawford; Bradley A Cahn; Rachel Beekman; Jennifer A Kim; Kevin T Gobeske; Nils H Petersen; Guido J Falcone; Emily J Gilmore; David Y Hwang; Adam S Jasne; Hardik Amin; Richa Sharma; Charles Matouk; Adrienne Ward; Joseph Schindler; Lauren Sansing; Adam de Havenon; Ani Aydin; Charles Wira; Gordon Sze; Matthew S Rosen; W Taylor Kimberly; Kevin N Sheth
Journal:  Sci Adv       Date:  2022-04-20       Impact factor: 14.957

8.  Bedside detection of intracranial midline shift using portable magnetic resonance imaging.

Authors:  Kevin N Sheth; Matthew M Yuen; Mercy H Mazurek; Bradley A Cahn; Anjali M Prabhat; Sadegh Salehi; Jill T Shah; Samantha By; E Brian Welch; Michal Sofka; Laura I Sacolick; Jennifer A Kim; Seyedmehdi Payabvash; Guido J Falcone; Emily J Gilmore; David Y Hwang; Charles Matouk; Barbara Gordon-Kundu; Adrienne Ward Rn; Nils Petersen; Joseph Schindler; Kevin T Gobeske; Lauren H Sansing; Gordon Sze; Matthew S Rosen; W Taylor Kimberly; Prantik Kundu
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.996

9.  Clinical experience regarding safety and diagnostic value of cardiovascular magnetic resonance in patients with a subcutaneous implanted cardioverter/defibrillator (S-ICD) at 1.5 T.

Authors:  Viktoria Holtstiege; Claudia Meier; Michael Bietenbeck; Grigorios Chatzantonis; Anca Florian; Julia Köbe; Florian Reinke; Lars Eckardt; Ali Yilmaz
Journal:  J Cardiovasc Magn Reson       Date:  2020-05-18       Impact factor: 5.364

10.  Clinical safety of ProMRI implantable cardioverter-defibrillator systems during head and lower lumbar magnetic resonance imaging at 1.5 Tesla.

Authors:  Wolfgang Rudolf Bauer; Dennis H Lau; Christian Wollmann; Andrew McGavigan; Jacques Mansourati; Theresa Reiter; Simone Frömer; Mark E Ladd; Harald H Quick
Journal:  Sci Rep       Date:  2019-12-03       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.